Guggenheim Capital’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $211K | Sell |
122,867
-25,483
| -17% | -$43.8K | ﹤0.01% | 1493 |
|
|
2025
Q1 | $494K | Buy |
148,350
+49,410
| +50% | +$165K | ﹤0.01% | 1206 |
|
|
2024
Q4 | $732K | Sell |
98,940
-10,880
| -10% | -$80.5K | 0.01% | 1072 |
|
|
2024
Q3 | $1.03M | Sell |
109,820
-2,651
| -2% | -$24.9K | 0.01% | 1085 |
|
|
2024
Q2 | $902K | Buy |
112,471
+35,008
| +45% | +$281K | 0.01% | 1175 |
|
|
2024
Q1 | $1.15M | Sell |
77,463
-31,638
| -29% | -$469K | 0.01% | 1119 |
|
|
2023
Q4 | $887K | Buy |
+109,101
| New | +$887K | 0.01% | 1210 |
|
|
2023
Q1 | – | Sell |
-111,286
| Closed | -$711K | – | 1961 |
|
|
2022
Q4 | $711K | Sell |
111,286
-564
| -0.5% | -$3.6K | 0.01% | 1329 |
|
|
2022
Q3 | $1.07M | Sell |
111,850
-16,701
| -13% | -$160K | 0.01% | 1110 |
|
|
2022
Q2 | $1.42M | Buy |
128,551
+15,438
| +14% | +$170K | 0.01% | 1057 |
|
|
2022
Q1 | $1.88M | Buy |
113,113
+8,517
| +8% | +$142K | 0.01% | 1050 |
|
|
2021
Q4 | $2M | Buy |
104,596
+9,297
| +10% | +$178K | 0.01% | 1055 |
|
|
2021
Q3 | $2.35M | Sell |
95,299
-2,761
| -3% | -$68.1K | 0.01% | 974 |
|
|
2021
Q2 | $2.55M | Buy |
98,060
+8,638
| +10% | +$225K | 0.02% | 957 |
|
|
2021
Q1 | $2.83M | Buy |
89,422
+20,024
| +29% | +$634K | 0.02% | 854 |
|
|
2020
Q4 | $3.22M | Sell |
69,398
-13,243
| -16% | -$614K | 0.02% | 762 |
|
|
2020
Q3 | $2.72M | Sell |
82,641
-29,961
| -27% | -$986K | 0.02% | 760 |
|
|
2020
Q2 | $3.09M | Buy |
+112,602
| New | +$3.09M | 0.02% | 705 |
|